| Authors: |
Kurokawa C; Virology and Vaccine Discovery, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Agrawal S; Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA., Mitra A; Biologics Engineering and Targeted Delivery, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA., Galvani E; Biologics Engineering and Targeted Delivery, Oncology R&D, AstraZeneca, Cambridge, UK., Burke S; Biologics Engineering and Targeted Delivery, Oncology R&D, AstraZeneca, Cambridge, UK., Varshine A; Biologics Engineering and Targeted Delivery, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA., Rothstein R; Biologics Engineering and Targeted Delivery, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA., Schifferli K; Biologics Engineering and Targeted Delivery, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA., Monks NR; Biologics Engineering and Targeted Delivery, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA., Foloppe J; Department of Research, Transgene SA, Illkirch-Graffenstaden, France., Silvestre N; Department of Research, Transgene SA, Illkirch-Graffenstaden, France., Quemeneur E; Department of Research, Transgene SA, Illkirch-Graffenstaden, France., Demeusoit C; Department of Research, Transgene SA, Illkirch-Graffenstaden, France., Kleinpeter P; Department of Research, Transgene SA, Illkirch-Graffenstaden, France., Sapra P; Biologics Engineering and Targeted Delivery, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA., Barrett C; Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA., Hammond SA; Biologics Engineering and Targeted Delivery, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA., Kelly EJ; Clinical Virology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Laliberte J; Virology and Vaccine Discovery, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Durham NM; Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA., Oberst M; Biologics Engineering and Targeted Delivery, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA., Broggi MAS; Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA. |
